STING1 and cancer: This triggered robust activation of STING signaling and enhanced antitumor immunity.[119a] Intravenous injection of SR@PMOF NPs in mice reversed the immunosuppressive TME and effectively controlled both primary and distant tumors, demonstrating the significant synergy between PDT‐induced immune activation and STING agonist‐based immunotherapy in cancer treatment.[119a]